iBio, Inc. Quarterly Depreciation in USD from Q3 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
iBio, Inc. quarterly/annual Depreciation history and growth rate from Q3 2012 to Q3 2024.
  • iBio, Inc. Depreciation for the quarter ending September 30, 2024 was $120K, a 27.3% decline year-over-year.
  • iBio, Inc. annual Depreciation for 2024 was $638K, a 5.34% decline from 2023.
  • iBio, Inc. annual Depreciation for 2023 was $674K, a 70.4% decline from 2022.
  • iBio, Inc. annual Depreciation for 2022 was $2.28M, a 382% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $120K -$45K -27.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q3 2023 $165K -$106K -39.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q3 2022 $2.24M $271K -$35K -11.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $2.28M $743K +$601K +423% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-27
Q1 2022 $1.67M $709K +$590K +496% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.08M $517K +$403K +354% Oct 1, 2021 Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $681K $306K +$209K +215% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $472K $142K +$67K +89.3% Apr 1, 2021 Jun 30, 2021 10-K 2022-10-11
Q1 2021 $405K $119K +$49K +70% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $356K $114K +$43K +60.6% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $313K $97K +$31K +47% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $282K $75K -$287K -79.3% Apr 1, 2020 Jun 30, 2020 10-K 2021-09-28
Q1 2020 $569K $70K -$271K -79.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $840K $71K -$293K -80.5% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 $1.13M $66K -$294K -81.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $1.43M $362K +$341M Apr 1, 2019 Jun 30, 2019 10-K 2020-10-13
Q1 2019 -$339M $341K -$341M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $1.41M $364K +$23K +6.75% Oct 1, 2018 Dec 31, 2018 10-Q 2019-02-13
Q3 2018 $1.39M $360K +$22K +6.51% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $1.37M -$340M -$341M -100487% Apr 1, 2018 Jun 30, 2018 10-K 2019-08-26
Q1 2018 $342M $341M* +$341M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $1.36M $341K +$15K +4.6% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-13
Q3 2017 $1.34M $338K +$14K +4.32% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $1.33M $339K +$25K +7.96% Apr 1, 2017 Jun 30, 2017 10-K 2018-09-18
Q1 2017 $1.3M $337K +$76K +29.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 $1.23M $326K +$325K +32500% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-14
Q3 2016 $900K $324K +$323K +32300% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $577K $314K Apr 1, 2016 Jun 30, 2016 10-K 2017-09-15
Q1 2016 $261K +$250K +2273% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $1K Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-21
Q3 2015 $1K $0 0% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-18
Q1 2015 $11K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-23
Q3 2014 $1K $0 0% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q3 2013 $1K +$1K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q3 2012 $0 Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.